in this issue
Regions :: Western Europe :: Belgium
EU fines six pharma firms for curbing entry of cheaper generic drugs
8:29 AM MDT | July 10, 2014 | Natasha Alperowicz
The European Commission announced on Wednesday that it has imposed fines totaling €427.7 million ($582.8 million) on the French pharmaceutical company Servier and five producers of generic drugs—Niche/Unichem; Matrix, now part of Mylan; Teva; Krka; and Lupin—for concluding a series of deals to protect Servier's best-selling blood pressure medicine, perindopril, from price competition by generics in the European Union. Through a technology acquisition and a series of patent settlements with generic rivals, Servier breached EU antitrust rules by...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee